Back to search

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Data up to Jan 2025

Published1991
Citations584
References48
Clinical Trials (1)

Total Citations Per Year

Abstract

References (48)

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

1984 • 3,268 citations

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 • 2,616 citations

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

1982 • 2,228 citations

A severe combined immunodeficiency mutation in the mouse

1983 • 2,193 citations

A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes

1986 • 1,787 citations

The SCID-hu Mouse: Murine Model for the Analysis of Human Hematolymphoid Differentiation and Function

1988 • 1,394 citations

Transfer of a functional human immune system to mice with severe combined immunodeficiency

1988 • 1,248 citations

Comparison of three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebrates

1986 • 678 citations

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency

1986 • 558 citations

Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

1984 • 529 citations

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1988 • 389 citations

Natural killer cells: definition of a cell type rather than a function

1987 • 385 citations

Infection of the SCID-hu Mouse by HIV-1

1988 • 368 citations

Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).

1985 • 362 citations

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1987 • 361 citations

Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

1985 • 307 citations

A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID Mice

1989 • 250 citations

Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.

1984 • 246 citations

Suppression of HIV Infection in AZT-Treated SCID-hu Mice

1990 • 193 citations

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1985 • 184 citations

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.

1987 • 172 citations

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.

1986 • 149 citations

Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice.

1990 • 149 citations

The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2

1986 • 145 citations

Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.

1988 • 131 citations

The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor

1987 • 128 citations

Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies.

1984 • 116 citations

Interaction of recombinant interferons with recombinant interleukin‐2: Differential effects on natural killer cell activity and interleukin‐2‐activated killer cells

1986 • 101 citations

Abelson virus-induced lymphomagenesis in mice.

1978 • 90 citations

Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency.

1987 • 82 citations

Growth of Human Tumors in Immune-Deficient scid Mice and nude Mice

1989 • 79 citations

The function of antigen-presenting cells in mice with severe combined immunodeficiency.

1985 • 76 citations

Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging

1991 • 72 citations

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.

1989 • 70 citations

T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice.

1987 • 59 citations

Establishment of a Human Cutaneous T-Cell Lymphoma in C.B-17 SCID Mice

1990 • 53 citations

Use of scid mice to identify and quantitate lymphoid-restricted stem cells in long-term bone marrow cultures

1989 • 47 citations

Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro

1989 • 43 citations

The biology of the SCID mutation

1989 • 32 citations

Immunoglobulin heavy chain gene diversification in the long‐term bone marrow culture of normal mice and mice with severe combined immunodeficiency

1987 • 28 citations

Natural killer cells: definition of a cell type rather than a function

1987 • 19 citations

Induction of lymphokine-activated killer cells against human leukemia cells in vitro

1989 • 19 citations

Lymphokine-activated killer cell activity after cryopreservation

1989 • 16 citations

Current Understanding of the Lymphokine-Activated Killer Cell Phenomenon

2015 • 12 citations

Technical aspects of lymphokine‐activated killer cell production

1988 • 11 citations

Use of scid mice to identify and quantitate lymphoid-restricted stem cells in long-term bone marrow cultures

1989 • 8 citations

Establishment of Assays for Human Hematopoietic Cells in Immune Deficient Mice

1989 • 6 citations

Human Tumor-Infiltrating Lymphocytes and Their Characterization

2018 • 1 citations

Cited By (0)

Loading...
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with… (1991) – The Journal of Experimental Medicine | Metascience Observatory Explorer